1
|
He C, Shen M, Morita K, Wang D, Kanazawa T, Yoshida Y. Nuclear factor of activated T cells as a marker of in vivo low‐dose dibenzo[
a
,
h
]anthracene exposure. J Appl Toxicol 2020; 40:1239-1247. [DOI: 10.1002/jat.3981] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Revised: 03/23/2020] [Accepted: 03/24/2020] [Indexed: 01/25/2023]
Affiliation(s)
- Cuiying He
- Department of Immunology and Parasitology, School of MedicineUniversity of Occupational and Environmental Health Kitakyushu Japan
- Department of Hematologythe Fourth Hospital of Hebei Medical University Shijiazhuang China
| | - Mengyue Shen
- Department of Immunology and Parasitology, School of MedicineUniversity of Occupational and Environmental Health Kitakyushu Japan
| | - Kentaro Morita
- Department of Immunology and Parasitology, School of MedicineUniversity of Occupational and Environmental Health Kitakyushu Japan
| | - Duo Wang
- Department of Immunology and Parasitology, School of MedicineUniversity of Occupational and Environmental Health Kitakyushu Japan
| | - Tamotsu Kanazawa
- Department of Immunology and Parasitology, School of MedicineUniversity of Occupational and Environmental Health Kitakyushu Japan
| | - Yasuhiro Yoshida
- Department of Immunology and Parasitology, School of MedicineUniversity of Occupational and Environmental Health Kitakyushu Japan
| |
Collapse
|
2
|
Yao P, Hongqian C, Qinghe M, Lanqin S, Jianjun J, Xiaohua Y, Xuetao W, Weidong H. Lack of TAK1 in dendritic cells inhibits the contact hypersensitivity response induced by trichloroethylene in local lymph node assay. Toxicol Appl Pharmacol 2016; 307:72-80. [DOI: 10.1016/j.taap.2016.07.019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Revised: 07/19/2016] [Accepted: 07/25/2016] [Indexed: 12/31/2022]
|
3
|
Zaccaria KJ, McClure PR. Using Immunotoxicity Information to Improve Cancer Risk Assessment for Polycyclic Aromatic Hydrocarbon Mixtures. Int J Toxicol 2013; 32:236-50. [DOI: 10.1177/1091581813492829] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Estimating cancer risk from environmental mixtures containing polycyclic aromatic hydrocarbons (PAHs) is challenging. Ideally, each mixture would undergo toxicity testing to derive a cancer slope factor (CSF) for use in site-specific cancer risk assessments. However, this whole mixture approach is extremely costly in terms of finances, time, and animal usage. Alternatively, if an untested mixture is “sufficiently similar” to a well-characterized mixture with a CSF, the “surrogate” CSF can be used in risk assessments. We propose that similarity between 2 mixtures could be established using an in vitro battery of genotoxic and nongenotoxic tests. An observed association between carcinogenicity and immunosuppression of PAHs suggests that the addition of immune suppression assays may improve this battery. First, using published studies of benzo[a]pyrene (BaP) and other PAHs, we demonstrated a correlation between the derived immune suppression relative potency factors (RPFs) for 9 PAHs and their respective cancer RPFs, confirming observations published previously. Second, we constructed an integrated knowledge map for immune suppression by BaP based on the available mechanistic information. The map illustrates the mechanistic complexities involved in BaP immunosuppression, suggesting that multiple in vitro tests of immune suppression involving different processes, cell types, and tissues will have greater predictive value for immune suppression in vivo than a single test. Based on these observations, research strategies are recommended to validate a battery of in vitro immune suppression tests that, along with tests for genotoxic and other nongenotoxic modes of cancer action, could be used to establish “sufficient similarity” of 2 mixtures for site-specific cancer risk assessments.
Collapse
Affiliation(s)
| | - Peter R. McClure
- SRC, Inc, Defense and Environmental Solutions, North Syracuse, NY, USA
| |
Collapse
|
4
|
Park YH, Bae HC, Jang Y, Jeong SH, Lee HN, Ryu WI, Yoo MG, Kim YR, Kim MK, Lee JK, Jeong J, Son SW. Effect of the size and surface charge of silica nanoparticles on cutaneous toxicity. Mol Cell Toxicol 2013. [DOI: 10.1007/s13273-013-0010-7] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
5
|
Chang DJ, Lee S, Jang J, Kim SO, Kim WJ, Suh YG. Part II. Development of novel colchicine-derived immunosuppressants with improved pharmacokinetic properties. Bioorg Med Chem Lett 2012; 22:6750-5. [DOI: 10.1016/j.bmcl.2012.08.068] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2012] [Revised: 08/15/2012] [Accepted: 08/17/2012] [Indexed: 10/28/2022]
|
6
|
Madrigal-Santillán E, Fragoso-Antonio S, Valadez-Vega C, Solano-Solano G, Zúñiga Pérez C, Sánchez-Gutiérrez M, Izquierdo-Vega JA, Gutiérrez-Salinas J, Esquivel-Soto J, Esquivel-Chirino C, Sumaya-Martínez T, Fregoso-Aguilar T, Mendoza-Pérez J, Morales-González JA. Investigation on the protective effects of cranberry against the DNA damage induced by benzo[a]pyrene. Molecules 2012; 17:4435-51. [PMID: 22499190 PMCID: PMC6268607 DOI: 10.3390/molecules17044435] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2012] [Revised: 03/19/2012] [Accepted: 03/20/2012] [Indexed: 02/07/2023] Open
Abstract
There are few reports that demonstrate the antigenotoxic potential of cranberries. Although the types of berry fruits consumed worldwide are many, this paper focuses on cranberries that are commonly consumed in Mexico (Vaccinium macrocarpon species). The purpose of the present study is to determine whether cranberry ethanolic extract (CEE) can prevent the DNA damage produced by benzo[a]pyrene (B[a]P) using an in vivo mouse peripheral blood micronucleus assay. The experimental groups were organized as follows: a negative control group (without treatment), a positive group treated with B[a]P (200 mg/kg), a group administered with 800 mg/kg of CEE, and three groups treated with B[a]P and CEE (200, 400, and 800 mg/kg) respectively. The CEE and benzo[a]pyrene were administered orally for a week, on a daily basis. During this period the body weight, the feed intake, and the determination of antigenotoxic potential were quantified. At the end of this period, we continued with the same determinations for one week more (recovery period) but anymore administration of the substances. The animals treated with B[a]P showed a weight increase after the first week of administration. The same phenomenon was observed in the lots combined with B[a]P and CEE (low and medium doses). The dose of 800 mg/kg of CEE showed similar values to the control group at the end of the treatment period. In the second part of the assay, when the substances were not administered, these experimental groups regained their normal weight. The dose of CEE (800 mg/kg) was not genotoxic nor cytotoxic. On the contrary, the B[a]P increases the frequency of micronucleated normochromatic erythrocytes (MNNE) and reduces the rate of polychromatic erythrocytes (PE) at the end of the treatment period. With respect to the combined lots, a significant decrease in the MN rate was observed from the sixth to the eighth day of treatment with the two high doses applied; the highest protection (60%) was obtained with 800 mg/kg of CEE. The same dose showed an anticytotoxic effect which corresponded to an improvement of 62.5% in relation to the animals administered with the B[a]P. In the second period, all groups reached values that have been seen in the control group animals. Our results suggest that the inhibition of clastogenicity of the cranberry ethanolic extract against B[a]P is related to the antioxidant capacity of the combination of phytochemicals present in its chemical composition.
Collapse
Affiliation(s)
- Eduardo Madrigal-Santillán
- Institute of Health Sciences, Autonomous University of Hidalgo State, Ex-Hacienda de la Concepción. Pachuca, Hidalgo, 42080, Mexico; (S.F.-A.); (C.V.-V.); (G.S.-S.); (C.Z.P.); (M.S.-G.); (J.A.I.-V.); (J.A.M.-G.)
| | - Sonia Fragoso-Antonio
- Institute of Health Sciences, Autonomous University of Hidalgo State, Ex-Hacienda de la Concepción. Pachuca, Hidalgo, 42080, Mexico; (S.F.-A.); (C.V.-V.); (G.S.-S.); (C.Z.P.); (M.S.-G.); (J.A.I.-V.); (J.A.M.-G.)
| | - Carmen Valadez-Vega
- Institute of Health Sciences, Autonomous University of Hidalgo State, Ex-Hacienda de la Concepción. Pachuca, Hidalgo, 42080, Mexico; (S.F.-A.); (C.V.-V.); (G.S.-S.); (C.Z.P.); (M.S.-G.); (J.A.I.-V.); (J.A.M.-G.)
| | - Gloria Solano-Solano
- Institute of Health Sciences, Autonomous University of Hidalgo State, Ex-Hacienda de la Concepción. Pachuca, Hidalgo, 42080, Mexico; (S.F.-A.); (C.V.-V.); (G.S.-S.); (C.Z.P.); (M.S.-G.); (J.A.I.-V.); (J.A.M.-G.)
| | - Clara Zúñiga Pérez
- Institute of Health Sciences, Autonomous University of Hidalgo State, Ex-Hacienda de la Concepción. Pachuca, Hidalgo, 42080, Mexico; (S.F.-A.); (C.V.-V.); (G.S.-S.); (C.Z.P.); (M.S.-G.); (J.A.I.-V.); (J.A.M.-G.)
| | - Manuel Sánchez-Gutiérrez
- Institute of Health Sciences, Autonomous University of Hidalgo State, Ex-Hacienda de la Concepción. Pachuca, Hidalgo, 42080, Mexico; (S.F.-A.); (C.V.-V.); (G.S.-S.); (C.Z.P.); (M.S.-G.); (J.A.I.-V.); (J.A.M.-G.)
| | - Jeannett A. Izquierdo-Vega
- Institute of Health Sciences, Autonomous University of Hidalgo State, Ex-Hacienda de la Concepción. Pachuca, Hidalgo, 42080, Mexico; (S.F.-A.); (C.V.-V.); (G.S.-S.); (C.Z.P.); (M.S.-G.); (J.A.I.-V.); (J.A.M.-G.)
| | - José Gutiérrez-Salinas
- Laboratory of Biochemistry and Experimental Medicine, Division of Biomedical Research, National Medical Center “20 de Noviembre”, ISSSTE. México D.F., 03229, Mexico;
| | - Jaime Esquivel-Soto
- Faculty of Dentistry, School Circuit S/N. UNAM. México D.F., 04510, Mexico; (J.E.-S.); (C.E.-C.)
| | - César Esquivel-Chirino
- Faculty of Dentistry, School Circuit S/N. UNAM. México D.F., 04510, Mexico; (J.E.-S.); (C.E.-C.)
| | - Teresa Sumaya-Martínez
- Secretary of Research and Graduate Studies, Autonomous University of Nayarit, “City of the culture Amado Nervo”, Boulevard Tepic-Xalisco S/N. Tepic, Nayarit, 28000, Mexico;
| | - Tomas Fregoso-Aguilar
- National School of Biological Sciences, IPN. Av. Wilfrido Massieu. Unidad A. López Mateos. Zacatenco. México D.F., 07700, Mexico; (T.F.-A.); (J.M.-P.)
| | - Jorge Mendoza-Pérez
- National School of Biological Sciences, IPN. Av. Wilfrido Massieu. Unidad A. López Mateos. Zacatenco. México D.F., 07700, Mexico; (T.F.-A.); (J.M.-P.)
| | - José A. Morales-González
- Institute of Health Sciences, Autonomous University of Hidalgo State, Ex-Hacienda de la Concepción. Pachuca, Hidalgo, 42080, Mexico; (S.F.-A.); (C.V.-V.); (G.S.-S.); (C.Z.P.); (M.S.-G.); (J.A.I.-V.); (J.A.M.-G.)
| |
Collapse
|
7
|
Lee S, Yun HS, Kim SH. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 2011; 32:9434-43. [PMID: 21889200 DOI: 10.1016/j.biomaterials.2011.08.042] [Citation(s) in RCA: 135] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2011] [Accepted: 08/16/2011] [Indexed: 01/17/2023]
Abstract
Mesoporous silica (MPS), synthesized via the supramolecular polymer templating method, is one of the most attractive nanomaterials for biomedical applications, such as drug delivery systems, labeling, and tissue engineering. The significant difference between MPS and general silica (colloidal silica) is the pore architectures, such as specific surface area and pore volume. The pore structures of nanomaterials have been considered to be one of the key conditions, causing nanotoxicity due to their different efficiency of cellular uptake and immune response. We first studied the influence of pore structural conditions of silica nanoparticles on both inflammation and apoptosis, in vitro and in vivo, by comparing MPS and colloidal silica, and defined underlying mechanisms of action. Both the MPS and colloidal silica nanoparticles are produced by almost similar synthetic conditions, except the use of polymer template for MPS. The specific surface area of colloidal silica and MPS was 40 and 1150 m(2) g(-1), respectively, while other conditions, including particle size (100 nm) and shape (spherical), were kept constant. In both MTT assay and FACS analysis, MPS nanoparticles showed significantly less cytotoxicity and apoptotic cell death than colloidal silica nanoparticles. MPS nanoparticles induced lower expression of pro-inflammatory cytokines, such as tumor necrosis factor-α, interleukin (IL)-1β, and IL-6, in macrophages. The reduced inflammatory response and apoptosis elicited by MPS nanoparticles were resulting from the reduction of mitogen-activated protein kinases, nuclear factor-κB, and caspase 3. In addition, using the local lymph node assay, a standalone in vivo method for hazard identification of contact hypersensitivity, we showed that colloidal silica nanoparticles act as an immunogenic sensitizer and induce contact hypersensitivity but not MPS nanoparticles. In conclusion, the pore architecture of silica nanoparticles greatly influences their biocompatibility and should be carefully designed. The MPS nanoparticles exhibit better biocompatibility than colloidal silica and promise excellent potential usage in the field of biomedical and biotechnological applications.
Collapse
Affiliation(s)
- Soyoung Lee
- Laboratory of Immunotoxicology, Department of Pharmacology, School of Medicine, Kyungpook National University, 101 Dong-In, Jung-Gu, Daegu 700-422, Republic of Korea
| | | | | |
Collapse
|
8
|
Oshida K, Maeda A, Kitsukawa M, Suga S, Iwano S, Miyoshi T, Miyamoto Y. Novel gene markers of immunosuppressive chemicals in mouse lymph node assay. Toxicol Lett 2011; 205:79-85. [PMID: 21621594 DOI: 10.1016/j.toxlet.2011.05.1017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2011] [Revised: 05/11/2011] [Accepted: 05/12/2011] [Indexed: 01/07/2023]
Abstract
The murine local lymph node assay (LLNA) is an immunologically based test of the sensitizing potential of immunotoxicants, but also evaluates immunosuppressive potential with good sensitivity and specificity. We conducted the LLNA with calcineurin inhibitors (tacrolimus and cyclosporin A), antimetabolites (methotrexate and azathioprine), steroids (dexamethasone and prednisolone), and an alkylator (cyclophosphamide). We performed a comprehensive analysis of results of gene expression in lymph nodes obtained in the LLNA using a highly sensitive DNA chip, 3D-Gene™, and the quantitative reverse transcription-polymerase chain reaction (qPCR). Zfp459 expression increased in all animals treated with immunosuppressive chemicals. Ltf, Cbll1 and Lias expression changed specifically in response to the calcineurin inhibitors, Fmo2 and 9630033F20Rik in response to the antimetabolites, Krt8, Gjb1, Hmha1 and Sfrs7 in response to the steroids, and Gbp1 and Mup5 in response to the alkylator. Therefore, these genes were considered novel markers for immunosuppression and their expression could be used to evaluate the mechanism of action of immunosuppressive chemicals.
Collapse
Affiliation(s)
- Keiyu Oshida
- Toxicology and Pharmacokinetics Laboratories, Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1, Tebiro, Kamakura, Kanagawa 248-8555, Japan
| | | | | | | | | | | | | |
Collapse
|
9
|
Baken KA, Pennings JLA, de Vries A, Breit TM, van Steeg H, van Loveren H. Gene expression profiling of Bis(tri-n-butyltin)oxide (TBTO)-induced immunotoxicity in mice and rats. J Immunotoxicol 2009; 3:227-44. [PMID: 18958704 DOI: 10.1080/15476910601023602] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Abstract
Bis(tri-n-butyltin)oxide (TBTO) is one of the organotin compounds that have been used as biocides and occur as persistent environmental pollutants. Human exposure to these compounds occurs through consumption of meat and fish products in which they accumulate. The most sensitive endpoint of TBTO exposure is immunotoxicity. TBTO causes thymus atrophy and thereby interferes with T-lymphocyte-mediated immune responses. Tributyltin compounds have been found to adversely affect a wide range of cellular components and processes in many species, organ systems, and cell types. Both inhibition of proliferation and induction of apoptosis have been observed in thymocytes. We conducted microarray experiments in mice and rats in order to investigate if the immunosuppressive actions of TBTO could be detected by gene expression profiling, and if so, to elucidate the mechanisms of action. Gene expression changes that were detected in mouse thymuses after exposure to a maximum tolerable dose of TBTO correlated to previously observed effects. Most notably, reduction of expression of cell surface determinants and T-cell receptor chains, suppression of cell proliferation, and a possible involvement of nuclear receptors in interference with lipid metabolism by TBTO were observed. The TBTO-induced thymus involution may therefore primarily be caused by inhibition of thymocyte proliferation. In contrast, in rats only limited effects of a lower dose of TBTO were found at the gene expression level in the thymus, even though thymus involution was observed. Here, most gene expression regulation by TBTO was detected in the liver. These preliminary results indicate that gene expression analysis is able to reveal effects of TBTO and to gain insight into its molecular mechanism of action. It may even be a suitable tool to investigate immunotoxicology in general. However, dose and inter-species differences are apparently clearly reflected in the gene expression profiles.
Collapse
Affiliation(s)
- Kirsten A Baken
- Department of Health Risk Analysis and Toxicology (GRAT), Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht University, Maastricht, The Netherlands.
| | | | | | | | | | | |
Collapse
|
10
|
Jung KM, Bae IH, Kim BH, Kim WK, Chung JH, Park YH, Lim KM. Comparison of flow cytometry and immunohistochemistry in non-radioisotopic murine lymph node assay using bromodeoxyuridine. Toxicol Lett 2009; 192:229-37. [PMID: 19879932 DOI: 10.1016/j.toxlet.2009.10.024] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2009] [Revised: 10/19/2009] [Accepted: 10/21/2009] [Indexed: 11/28/2022]
Abstract
Non-radioisotopic local lymph node assay (LLNA) employing 5-bromo-2'-deoxyuridine (BrdU) with flow cytometry (FACS) or immunohistochemistry (IHC) is gaining attention due to a regulatory issue of using radioisotope, (3)H-thymidine, in vivo in traditional LLNA. In this study, to compare the performance of these non-radioisotopic endpoints, 7 chemicals with known sensitizing potencies were examined in LLNA. Mice were topically treated with chemicals or vehicle on both ears for 3 days. After intraperitoneal injection of BrdU, bilateral lymph nodes were isolated separately and undergone respectively, FACS or IHC to determine BrdU incorporated lymph node cells (LNCs). Weight and histology of treated ears were also examined to evaluate chemical-induced edema and irritation. Both FACS and IHC could successively identify the skin sensitizers from non-sensitizers. Comparison of FACS and IHC with traditional LLNA revealed that FACS has a higher sensitivity although both assays produced comparable sensitivity and performance to traditional LLNA. In conclusion, non-radioisotopic LLNA using FACS and IHC can successfully detect sensitizers with a good correlation to traditional LLNA. Notably, FACS showed almost equivalent sensitivity and accuracy to traditional LLNA.
Collapse
Affiliation(s)
- Kyoung-Mi Jung
- Amorepacific Corporation R&D Center, Giheung-gu, Yongin-si, Republic of Korea
| | | | | | | | | | | | | |
Collapse
|
11
|
Corsini E, Roggen EL. Immunotoxicology: Opportunities for Non-animal Test Development. Altern Lab Anim 2009; 37:387-97. [DOI: 10.1177/026119290903700409] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
At present, several animal-based assays are used to assess immunotoxic effects such as immunosuppression and sensitisation. The use of whole animals, however, presents several secondary issues, including expense, ethical concerns and relevance to human risk assessment. There is a growing belief that non-animal approaches can eliminate these issues without impairing human safety, provided that biological markers are available to identify the immunotoxic potentials of new chemicals to which humans may be exposed. Driven by the 7th Amendment to the EU Cosmetics Directive, the new EU policy on chemicals (the REACH system), proposals to update the European legislation on the protection of animals used in research, and emerging visions and strategies for predicting toxicity, such in vitro methods are likely to play a major role in the near future. The realisation that the immune system can be the target of many chemicals, resulting in a range of adverse effects on the host's health, has raised serious concerns from the public and within the regulatory agencies. Hypersensitivity and immunosuppression are considered the primary focus for developing in vitro methods in immunotoxicology. However, in vitro assays to detect immunostimulation and autoimmunity are also needed. This review of the state-of-the-art in the field of in vitro immunotoxicity, reveals a lack of cell-based immunotoxicity assays for predicting the toxicity of xenobiotics toward the immune system in a simple, fast, economical and reliable way.
Collapse
Affiliation(s)
- Emanuela Corsini
- Laboratory of Toxicology, Department of Pharmacological Sciences, Faculty of Pharmacy, University of Milan, Milan, Italy
| | - Erwin L. Roggen
- Department of Pharma Protein Development, Novozymes A/S, Bagsvaerd, Denmark
| |
Collapse
|
12
|
Rossano JW, Denfield SW, Kim JJ, Price JF, Jefferies JL, Decker JA, Smith EO, Clunie SK, Towbin JA, Dreyer WJ. Assessment of the Cylex ImmuKnow cell function assay in pediatric heart transplant patients. J Heart Lung Transplant 2008; 28:26-31. [PMID: 19134527 DOI: 10.1016/j.healun.2008.10.001] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2008] [Revised: 10/04/2008] [Accepted: 10/14/2008] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND The Cylex ImmuKnow (Cylex, Columbia, MD) cell function assay (CICFA) is a commercially available test of immune response that purportedly identifies solid organ transplant patients at risk for either acute rejection (AR) or infection. Data on the utility of this test in pediatric heart transplant patients are very limited. This study tested the hypothesis that CICFA is a clinically useful test in this transplant population. METHODS All children undergoing heart transplantation at the study center (1989-2006) for whom CICFA levels were obtained were reviewed. The association of CICFA levels with episodes of AR and significant infections was determined. RESULTS Among 83 patients (34 girls, 41%), 367 CICFA levels were obtained (median, 4.0; interquartile range [IQR], 2.0-6.0 per patient). There were 26 episodes of AR in 17 patients (20%) and 38 infections in 34 patients (41%). CICFA levels were similar among patients with AR at the time of the CICFA measurement (median, 325 [IQR, 163-480] adenosine triphosphate [ATP] ng/ml) vs patients without AR (median, 330 [IQR, 227-441] ATP ng/ml; p = 0.36). CICFA levels were similar among patients with infections within 1 month of CICFA measurement (median, 295 [IQR, 216-366] ATP ng/ml) and those without infections (median, 330 [IQR, 226-453] ATP ng/ml; p = 0.24). CONCLUSIONS The CICFA is not predictive of AR or significant infections in pediatric heart transplant patients. On the basis of the available evidence, this assay cannot be recommended as part of the routine management of pediatric heart transplant patients.
Collapse
Affiliation(s)
- Joseph W Rossano
- Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Piccotti JR, Kawabata TT. Use of an Ex Vivo Local Lymph Node Assay to Assess Contact Hypersensitivity Potential. J Immunotoxicol 2008; 5:271-7. [DOI: 10.1080/15376510802311961] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Affiliation(s)
- Joseph R. Piccotti
- Drug Safety Research & Development, Pfizer Global Research and Development, Ann Arbor, Michigan, USA
| | - Thomas T. Kawabata
- Drug Safety Research & Development, Pfizer Global Research and Development, Groton, Connecticut, USA
| |
Collapse
|
14
|
Baken KA, Pennings JL, Jonker MJ, Schaap MM, de Vries A, van Steeg H, Breit TM, van Loveren H. Overlapping gene expression profiles of model compounds provide opportunities for immunotoxicity screening. Toxicol Appl Pharmacol 2008; 226:46-59. [DOI: 10.1016/j.taap.2007.08.026] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2007] [Revised: 08/17/2007] [Accepted: 08/29/2007] [Indexed: 11/28/2022]
|
15
|
de Jonge JD, Ezendam J, Knippels LMJ, Odink J, Pourier MS, Penninks AH, Pieters R, van Loveren H. Bis(tributyltin)oxide (TBTO) decreases the food allergic response against peanut and ovalbumin in Brown Norway rats. Toxicology 2007; 239:68-76. [PMID: 17669578 DOI: 10.1016/j.tox.2007.06.090] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2007] [Revised: 06/19/2007] [Accepted: 06/19/2007] [Indexed: 01/07/2023]
Abstract
Other factors than the allergen itself may be of importance in the development of food allergy. This report describes the influence of the immunosuppressive compound bis(tributyltin)oxide (TBTO), present in the food chain, on the development of food allergy to peanut or ovalbumin in Brown Norway (BN) rats. To study these effects BN rats were sensitized to either 1 or 10mg peanut or ovalbumin by daily oral gavage and the TBTO-groups were fed a diet containing 80 mg TBTO per kg diet. Co-exposure to TBTO not only resulted in decreased general immunologic parameters such as weights of mesenteric lymph nodes and Peyer's patches, lymphocyte proliferation rates in splenocytes, but also on allergic parameters. In the peanut allergen-model TBTO decreased allergen-specific Th2 cytokine production by spleen cells, number of eosinophilic and basophilic granulocytes in the blood and production of mast cell protease II after oral food challenge. In the ovalbumin allergen-model TBTO decreased the number of eosinophilic and basophilic granulocytes, allergen-specific IgE and production of mast cell protease II after oral food challenge. The data imply that in the process of risk assessment of food allergy attention should be given to immunomodulating compounds present in the diet.
Collapse
Affiliation(s)
- Jonathan D de Jonge
- University Maastricht, Department of Health Risk Analysis and Toxicology, Universiteitssingel 50, Maastricht, The Netherlands.
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Vandebriel RJ, Gremmer ER, van Hartskamp M, Dormans JAMA, Mooi FR. Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy models. CLINICAL AND VACCINE IMMUNOLOGY : CVI 2007; 14:211-9. [PMID: 17202304 PMCID: PMC1828861 DOI: 10.1128/cvi.00306-06] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
We have previously shown that in mice, diphtheria-tetanus-acellular pertussis (DTaP) vaccination before Bordetella pertussis infection resulted in, besides effective clearance, immediate hypersensitivity (lung eosinophilia, increased total serum immunoglobulin E [IgE], and increased ex vivo Th2 cytokine production by cells from the bronchial lymph nodes). To better appreciate the extent of these findings, we measured DTaP vaccination effects in the local lymph node assay (LLNA) and an ovalbumin (OVA) lung allergy model. In the LLNA, mice were vaccinated or adjuvant treated before being sensitized with trimellitic anhydride (TMA; inducing a Th2-directed response) and dinitrochlorobenzene (DNCB; inducing a Th1-directed response). Compared to the adjuvant-treated controls, the vaccinated mice showed a decreased response to TMA and (to a much lesser extent) an increased response to DNCB. The decreased response to TMA coincided with increased transforming growth factor beta levels. With the exception of filamentous hemagglutinin, all vaccine constituents contributed to the decreased response to TMA. In the lung allergy model, sensitization induced OVA-specific IgE, lung pathology (peribronchiolitis, perivasculitis, and hypertrophy of the bronchiolar mucus cells) and increased the number of eosinophils, lymphocytes, and neutrophils in the bronchoalveolar lavage fluid. Vaccination failed to modulate these parameters. In conclusion, although DTaP vaccination may affect the LLNA response, we found no evidence of an effect on lung allergy.
Collapse
Affiliation(s)
- Rob J Vandebriel
- Laboratory for Toxicology, Pathology and Genetics, National Institute of Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands.
| | | | | | | | | |
Collapse
|
17
|
Woolhiser MR, Houtman CE, Waechter JM. Acetone in drinking water does not modulate humoral immunity in mice as measured by the antibody, plaque-forming cell assay. Int J Toxicol 2006; 25:333-9. [PMID: 16940005 DOI: 10.1080/10915810600840826] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
It has been reported that the repeated topical, nonoccluded application of acetone may modulate antibody production in mice, thus producing humoral immunosuppression. However, the evaporative loss expected following nonoccluded dermal application of acetone makes the systemic effect seem unlikely. This study was designed to investigate the immunotoxicity potential of acetone in mice following a more direct systemic route of dosing via drinking water for 28 days. CD-1 male mice consumed average daily acetone doses of 121, 621 or 1144 mg/kg/day. The antibody, plaque-forming cell (AFC) assay was performed to measure the T cell-dependent, anti-sheep red blood cell immunoglobulin M (IgM) response, and hematology and thymus weights were evaluated to provide additional insight into the potential effects to the immune system. Body weights, white blood cell (WBC), numbers, red blood cell (RBC) counts, and hemoglobin and hematocrit levels showed no treatment-related effects at any dose of acetone. Eosinophil percentages were variable but also showed no dose-related trends. Spleen and thymus weights were not statistically different from controls and there were no effects on spleen cellularity or AFC response as a result of acetone administration. The AFC responses ranged from 1088 to 1401 AFCs/10(6) splenocytes and were not statistically different from controls (1277 AFCs/10(6) cells). Mice treated with cyclophosphamide (20 mg/kg) on days 25 to 28 demonstrated a 94% reduction in AFC/10(6) cells. Thus, the direct systemic administration of acetone did not produce evidence for immunotoxicity in CD-1 mice and the no observed adverse effect level (NOAEL) in this study was determined to be 1144 mg/kg/day.
Collapse
Affiliation(s)
- Michael R Woolhiser
- Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, Michigan 48674, USA.
| | | | | |
Collapse
|
18
|
Baken KA, Ezendam J, Gremmer ER, de Klerk A, Pennings JLA, Matthee B, Peijnenburg AACM, van Loveren H. Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression. Int J Food Microbiol 2006; 112:8-18. [PMID: 16875751 DOI: 10.1016/j.ijfoodmicro.2006.06.009] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2005] [Revised: 05/19/2006] [Accepted: 06/02/2006] [Indexed: 11/24/2022]
Abstract
Lactic acid bacteria are claimed to have immunomodulating effects. Stimulation as well as suppression of T helper (Th)1 mediated immune responses, have been described for various strains. Experiments involving Lactobacillus casei Shirota (LcS) detected mainly enhancement of innate immune responses and promotion of Th1 mediated immune reactivity. To confirm and further investigate modulation of Th1 responses and development of autoimmune disease by LcS, the consequences of oral administration of LcS were assessed in several experiments. The effect of LcS varied between the different models. No modulation was found in the mitogen-induced cell proliferation and cytokine release assays in mesenteric lymph nodes of Wistar rats. LcS inhibited the Th1 mediated immune response in an adapted murine Local Lymph Node Assay (LLNA) in BALB/c mice, whereas experimental autoimmune encephalomyelitis (EAE) in Lewis rats was aggravated. These varying effects on Th1 responses indicate that beneficial as well as harmful effects on immune related disorders could occur after LcS consumption. Since microarray analysis is suggested to be more sensitive and predictive than functional tests, gene expression profiling was included as an alternative endpoint in the testing of immunomodulation. The detected gene expression profiles did not reflect the effects of LcS on the immune system. Microarray analysis may therefore have no more predictive value than immune function assays when investigating immunomodulation by probiotics. To gain further insight into effects of probiotics on immune function, experiments including cytokine assays and gene expression analysis combined with disease models could be useful.
Collapse
Affiliation(s)
- Kirsten A Baken
- Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Department of Health Risk Analysis and Toxicology (GRAT), Maastricht University, Maastricht, The Netherlands
| | | | | | | | | | | | | | | |
Collapse
|